Objectives: The aim of this study was to investigate the secretion of prostacyclin (PGIz) 
Introduction
The vascular endothelium is a complex modulator of a variety of biological systems. It provides an inner lining of the blood vessels and has a crucial role in hemostasis, vascular tone, inflammation and angiogenesis. ECs produce among other substances: prostacyclin (PGI2), tissue plasminogen activator (tPA), its inhibitor PAI-1, thrombomodulin (TM) and protein C, all factors being of great importance in the maintenance of blood fluidity. PGI2 is a short-acting powerful vasodilator and plays a very important role in the negative control of platelet aggregation especially in situations in which platelet reactivity might be enhanced due to local tissue damage. L2
Thrombin has been reported to effect the synthesis, release or activation of a variety of plasma compoPlease address all correspondence to: Caroline Gillis, Karolinska Institute, Department of Neuroscience, Doktorsringen 17, S-171 77 Stockholm, Sweden. nents through its interaction with the vascular endothelium. 3'4 It proteolytically converts fibrinogen into fibrin and in the process binds the platelets to each other and to the vessel wall. Thrombin has previously been shown to stimulate PGI 2 production in several cultured human cell types, e.g. umbilical cord and great saphenous vein endothelial cells (HUVECs, HSVECs). 1 '5-7 tPA is the most important factor in the activation of the fibrinolytic system by conversion of plasminogen to plasmin, which in turn converts fibrin to soluble degradation products. Impaired fibrinolytic function caused by elevated plasma PAI-1 is the most commonly observed disturbance in patients with thrombotic diseases, both venous and arterial, s
Other endothelial-dependent mechanisms that possibly regulate the fibrinolytic pathway are the activation of protein C 9 and the thrombin-induced decline of intracellular plasminogen activator activity and release as described for bovine aortic endothelial cells 1078-5884/96/020127 + 07 $12.00/0 © 1996 W. B. Saunders Company Ltd. in culture. 3 Rapid activation of protein C occurs when thrombin binds to an endothelial surface receptor, z° Thrombin and TM form a complex which activates protein C, which in the presence of protein S bound to the endothelial surface, inactivates factor Va and VIIIa (vWF). 1~,~2
A feature that uniquely distinguishes natural blood vessels from their artificial counterparts is the presence of an endothelial cell lining. Creating a nonthrombogenic surface on prosthetic materials is a major challenge. Earlier clinical studies with intraoperatively recruited and low-density seeded ECs did not significantly improve the graft performanceY Recent studies have shown that cultured adult HSVECs can be used for endothelialisation of synthetic vascular grafts as well as biological and mechanical heart-valves. 6"~4-~6 Preoperative in vitroendothelialisation on human blood derived fibrin glue on ePTFE, is the only method evaluated in humans. 17'18 For any investigation concerning ECfunction in vitro or where the outcome is dependent on the anti-thrombotic or fibrinolytic activity of ECs, the choice of matrix for attachment may be crucial. Although one obvious aim of seeding ECs onto cardiovascular prostheses is to prevent thrombus formation, little is known about EC-function after attachment to prosthetic materials.
In this studN ELISA techniques were employed to compare the PGI2-, tPA-antigen-(tPA:ag) and PAI-1 release by adult HSVECs seeded on different matrices commonly used for in vitro experiments or for attachment to cardiovascular prostheses. This included deendothelialised porcine aorta and vascular expanded polytetrafluorethylene (ePTFE) grafts. Special emphasis was put on the comparison between collagen type-I and human serum coated ePTFE grafts. 15"19 PGI T production was also investigated after thrombin stimulation.
Material and Methods

Isolation, cultivation and characterisation of endothelial cells
ECs from 3-5 cm long, residual segments of the great saphenous vein received from patients undergoing coronary bypass surgery, were isolated and cultured as described previously. 
Preparation of matrices
Gelatin: As described above for routine culture.
Excess solution was removed before seeding.
Collagen type-I gel:
The method used by Montesano et al. 2° was used with minor modifications. Briefly, the collagen (Rat tail Boehringer Mannheim, GmbH, Germany) was dissolved in 0.2 M, mixed with MEM (10 × ), buffered with HEPES (Gibco, Scotland) and NaHCO3 to a final collagen concentration of 1.8 g/1. pH was adjusted with NaOH. To each well 0.3 ml was added and the collagen was allowed to solidify at 37°C for 30 min.
Fibronectin: Purified human fibronectin (Boehringer Mannheim) was used. The lyophilisate was dissolved in sterile water to a concentration of 1 mg/ml. Aliquots were diluted in MEM to a final concentration of 50 rag/1. 5/xg/cm 2 was pipetted to each well and incubated for 45 min at room temperature. The excess solution was carefully removed before cell seeding.
Fibrin glue: A gel was made using Tissucol due S, thrombin (Once®) and kleberproteinl6sung Zu (ERSTA®) which were mixed 1:1 according to the manufacturers instructions. A gel was formed immediately.
Cells seeded on uncoated plastic wells were used as controls. On the above mentioned matrices, HSVECs were seeded at a density corresponding to 100000 cells/cm 2 .
Preparation of ePTFE vascular graft surfaces
Serum precoating ePTFE (W.L. Gore and Associates, Flagstaff, AZ, Eur J Vasc Endovasc Surg Vol 11, February 1996 U.S.A.) grafts with the inner diameter of 8 mm were used. 15-20 ml (1.0-1.3 ml/cm 2 graft inner surface) pooled heat-inactivated HS was pressed through the graft wall as described previously, 19 emptied and left to dry at room temperature for 45 rain. The grafts were filled with a cell suspension corresponding to 200 000 cells/cm 2 and were rotated stepwise as previously described. 15 To allow complete endothelialisation and good adherence, seeded grafts were kept for two days under culture conditions in medium containing 30% pooled human serum and antibiotics before experiments. The grafts were then carefully cut into 0.5 cm circular pieces with a scalpel blade and put into culture wells as above.
Collagen type-I precoating
Collagen I (rat tail Boeringer Mannheim) was dissolved in 10 ml sterile HAc (1 M) to a concentration of 3 g/1 and mixed with D-MEM (Dulbecco's-Modified Eagle's Medium, Gibco) 1:1 at 20°C. To allow the collagen to solidify, the pH was increased to 7.5-8 by the addition of 1M NaOH. A volume corresponding to 0.3 ml/cm ~ graft inner surface was pressed through the graft wall as previously described. 19 The graft was allowed to dry for 45 min at room temperature. Cells were seeded as described for serum precoated grafts.
Preparation of porcine aorta
Porcine aorta pieces were mechanically de-endothelialised using a scalpel blade followed by devitalisation and storage in sterile de-ionised water containing antibiotics until seeding. 21 Before seeding, the porcine aorta was allowed to soak in culture media for 2h and then cut into pieces measuring approximately 1 cm 2. Cells were seeded at a density corresponding to 200 000 cells/cm 2.
Prostacyclin assay
Unstimulated cultures on the respective matrices or grafts were compared to thrombin-stimulated cultures (0.5 U/ml in MEM, Sigma Chemical Co, St. Louis, MO, U.S.A.) for 30 min at 37°C. The supernatants were collected and stored at -20 ° until analysis. PGI2 concentrations were assayed using enzyme-linked immunosorbent assay-(ELISA) kits of its stable metabolite 6-keto prostaglandin-Flc~ (Cayman Chemical Co, MI, U.S.A.).
t PA:a g/PAI-l-assays
Following the experiments for detection of prostacydin production as described above, 1-2 ml MEM with the addition of 2% HS was added to the wells and maintained for 24 h at 37°C. The supernatants were collected and analysed for tPA:ag and PAI-1 using ELISA techniques (Biopool TintElize TM tPA and Biopool Imulyse TM PAI-1) according to the manufacturers instructions.
Determination of cell numbers
Previous investigations have shown that the inoculated number of cells should be as described above to achieve immediate confluency and to achieve a similar cell density. The HSVECs on the different matrices and grafts were fixed and stained using crystal violet (0.1% in 20% ethanol) for 10 min and allowed to dry for 6-12h at room temperature before examination. There was minimal shrinkage of ePTFE as well as porcine aorta after this period. The cultures and surfaces of the grafts were examined in a Nikon microphot inverted microscope or a Leica fluovert Fu microscope. The ePTFE-rings were cut open prior to staining. The cell number/cm 2 was determined on video printouts and micrographs, including scale bars, in areas of 100 × 100 ~m at four randomly selected places on each matrix and graft type for each experiment.
Statistical analysis
Data obtained from cells on different matrices were comparable within each experiment due to the facts that the cells used were derived from the same patient, were in the same passage and the number of cells/cm 2 were calculated and differences were compensated for. The mean of triplicate cultures on a single matrix in each experiment was used as a single data point in a paired, two-tailed Student's t-test. The number of experiments (n) for each matrix or pre-coated graft varied between 3-8 depending on accessability (pigs) and economical reasons (fibrin glue).
Results
PGI2, tPA:ag and PAI-1
In media collected from cells cultured on uncoated plastic, the mean PGI2 concentration was 695 pg/105 cells. When stimulated with thrombin a 2.5 fold increase in concentration was found. The basal (nonstimulated) levels of PGI 2 concentration was higher, but not statistically significant, in media collected from cells cultivated on fibrin glue (1800 pg/105 cells), porcine aorta (1600 pg/105 cells) and ePTFE coated with human serum (1650 pg/105 cells) (Fig. 1) as compared to cells grown on plastic and gelatin. The Eur J Vasc Endovasc Surg Vo111, February 1996 cells responded with a significant increase in PGI2 production as compared to their unstimulated counterparts, on all matrices investigated (Fig. 1 ). When stimulated with thrombin, the highest level of PGI 2 was found in media collected from cells seeded on collagen precoated ePTFE grafts (3800 pg/105 cells) and collagen type I gel (3750 pg/105 cells) (Fig. 1) .
The mean concentration of tPA:ag in media from cells cultured on plastic was 0.50 ng/105 cells. The increase of tPA:ag concentration in media from cells cultured on collagen type-I gel was 4.7-, fibronectin 1.9-, pig aorta 1.9-, gelatin 1.8-and on fibrin glue 1.5-fold. In media collected from cells seeded on collagen type-I or human serum precoated ePTFE grafts, the concentrations of tPA were 0.47 ng/10 s cells and 0.58 ng/10 s cells respectively (Fig. 2) .
The mean PAI-1 concentration in supernatants from cells cultured on plastic was 90 ng/105 cells. The increase of PAI-1 concentration in media from cells cultured on fibrin glue was 2.2-, pig aorta 2.1-, collagen type-I 1.9-, fibronectin 1.5-and on gelatin 1.4-fold (Fig. 3) . The mean PAI-1 levels in media collected from cells cultured on collagen type-I and serum precoated ePTFE grafts were 80 ng/105 cells and 64 ng/105 cells respectively (Fig. 3) .
Discussion
Recent techniques for culture of human endothelial cells allow studies that reflect the function of the human endothelium. It is of obvious importance if vascular ECs exhibit an altered antithrombotic or thrombolytic capacity depending on their origin, culture technique or the subendothelial matrix the cells are cultured on. In this study, differences in the secretion of PGI 2, tPA:ag and PAI by HSVECs were observed 2 days after seeding onto the underlying matrix. The culture technique used in this study is an alternative to media containing heparin and endothelial cell growth factor. We omitted the cyclic AMPelevating factors 2 days prior to the experiments to avoid a cAMP-induced effect at the time of experiments. Different results due to culture techniques cannot be ruled out. Interestingly, heparin and ECGS have been shown to supress prostacyclin production. 22 While HSVECs on uncoated plastic and the commonly used gelatin precoating revealed a lower basal prostacyctin secretion, the cells on all matrices responded with a large increase in PGI2 production upon thrombin stimulation. This indicates that the cells were capable of an adequate biological response under all circumstances employed. The highest production of PGI 2 was noted by stimulated cells seeded on collagen type-I, precoated ePTFE grafts and porcine aorta. However, there was a variation found in the levels of PGI 2 production between the individual donors which is in accordance to previous studies. 6'7 The 2 to 3-fold increase of PGI 2 production after thrombin stimulation is also similar to previous results obtained on HSVECs in the absence of exogenous arachidonate. 7
The tPA:ag levels produced by HSVECs seeded on collagen type-I were significantly higher, compared to other matrices investigated. To our knowledge, it has not previously described that collagen type-I influences the tPA production of HSVECs. Other investigators 7 have shown that prostacyclin and t-PA:ag secretion from HSVECs are larger from cells seeded on fibronectin-vs. uncoated ePTFE. However, the data are not comparable to the data presented in this study since these were not correlated to cell number. The 
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Fibrin glue ePTFE coll. Gelatin Porcine aorta ePTFE s.p. relatively high levels of PAI-1 and low levels of tPA during culture may well be induced by the presence of TGFG1 in serum, z3'24 and therefore the choice of serum can also give somewhat different results between different investigators. Since we are at present using serum pre-coated ePTFE grafts for endothelialisation clinically, we challenged the serum coating technique with collagen type-I coated grafts. It was shown that PAI-1 secretion by cells seeded on ePTFE, irrespective of the coating, tended to be lower than on the different matrices tested in culture wells as well as on porcine aorta. The only significant difference in t-PA secretion was obtained in comparison to collagen type-1 gel. This could be explained by the close relation to ePTFE which partly limits tPA/PAI-1 expression or secretion. Another possibility is that PAI-1, and tPA may be immobilised on ePTFE. It is difficult to determine the actual collagen fibre density on ePTFE at the time of seeding as compared to the collagen gel formed in the wells. The differences in tPA secretion may be explained by the fact that the collagen fibre density influences the EC function. The attachment of HSVECs to serum-pre-coated ePTFE is dependent on a certain amount of serum being pressed through the graft wall 15'19 and the serum pre-coating technique is therefore not applicable in culture wells and direct comparisons cannot be made.
The tPA:ag levels described in this study are lower than the tPA:ag secretion by HUVECs seeded on uncoated plastic of 2.17 ng/10 s cells/24h described by Wojta et al. 2~ It must be remembered that the cells used in our study were derived from patients with atherosclerosis requiring a coronary bypass operation. The donor cells may have exhibited abnormal functions. 26"27 However, these patients are typical recipients of an endothelialised graft. The accessibility of normal HSVECs is a limitation for making comparative studies.
Endothelial cell seeding of synthetic and biological grafts have been promoted as a method of improving patency and durability of e.g. heart valves. 14'21 Fibrin glue has been used as a matrix for seeding of HSVECs on vascular ePTFE grafts, z8 Interestingly, the addition of the protease inhibitor aprotinin has then been necessary to prevent cellular detachment ~8'29 due to EC-plasminogen activit3a Fibrin glue is currently not approved by the U.S. Food and Drug Administration and other clinically applicable matrices have been sought. Serum precoating appears to be a safe and simple method to achieve a confluent and flow resistant endothelium on ePTFE. ~s Our preliminary data in a clinical study suggest that an antithrombotic function is maintained by ECs seeded on serum precoated ePTFE.
In conclusion, the choice of matrix affects the amount of PGIz, tPA:ag and PAI-1 secreted. Collagen type-I gel was shown to be the superior matrix in terms of high tPA production. Although prostacyclh~ secretion on collagen type-I or serum coated ePTFE was comparable, secretions of tPA and PAI-1 were lower, indicating unique properties of human saphenous vein endothelial cells on ePTFE. This emphasises the importance of consistency when conducting and comparing in vitro experiments. It also suggests that when ECs are used for clinical purposes, the EC function may differ at the time of implantation depending on the type of prosthetic material and precoating chosen.
